By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Protein Sciences Corporation 

1000 Research Parkway

Meriden  Connecticut  06450  U.S.A.
Phone: 203-686-0800 Fax: 203-686-0268



Company News
Protein Sciences Corporation New York Facility Receives FDA Licensure To Manufacture Flublok 5/13/2015 3:37:39 PM
Protein Sciences Corporation Release: Clinical Efficacy Study Of Flublok® Quadrivalent Compares Flublok To A Traditional Egg-Based Flu Vaccine 1/29/2015 8:31:17 AM
Frost & Sullivan New Product Innovation Award Conferred On Protein Sciences Corporation For Flublok® Influenza Vaccine 12/30/2014 7:38:41 AM
Protein Sciences Corporation, UMN Pharma And IHI Corporation Enter Into An Agreement To Evaluate Sourcing Flublok® From Japan 12/22/2014 8:27:06 AM
Protein Sciences Corporation Release: Flublok Technology Could Solve The Problem Of Ineffective Flu Vaccines 12/15/2014 8:21:04 AM
Protein Sciences Corporation Release: Flublok® Influenza Vaccine Now Approved For Adults Ages 18 And Older 10/30/2014 7:29:04 AM
Protein Sciences Corporation Expects To Begin Testing Ebola Vaccine 10/27/2014 3:18:30 PM
Ebola Clinical Trials: Big Name Players In The Ebola Race 10/20/2014 3:28:01 AM
Protein Sciences Corporation Release: Flublok® Influenza Vaccine Now Available for the 2014/2015 Influenza Season 9/29/2014 10:13:35 AM
Protein Sciences Corporation And Diamyd Medical AB Deepen Commitment To Develop New Treatment For Diabetes 9/17/2014 7:43:53 AM